2Hook EW 3rd.Syphilis and HIV infection[J].Infect Dis,1989,160(3):530-534
3Theus SA,Harrich DA,Gaynor R,et al.Treponema pallidum,liporoteins,and syntheitc lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation[J].J Infect Dis,1998,177(4):941-950
4Sellati TJ,Wilkinson DA,Sheffield JS,et al.Virulent Treponema pallidum,liporotein,and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1[J].J Infect Dis,2000,181(1):283-293
5Collis TK,Celum CL.The clinical manifestation and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men[J].Clin Infect Dis,2001,32(4):611-622
6Centers for Disease Control and Prevention.1998 Guidelines for treatment of sexually transmitted disease[J].MMWT Morb Mortal Wkly Rep.1998,47(RR-1):1-111
二级参考文献4
1Schofer H, Imhof M, Thoma-Greber E, et al. Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med, 1996, 72:176-181.
2Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis, United States. Sex Transm Dis, 2000, 27:53-59.
3Kidan KG, Fantahun M, Azeze B. Seroprevalence of human immunodeficiency virus infection and its association with syphilis seropositivity among antenatal clinic attenders at Debretabor Rural Hospital,Ethiopia. East Afr Med J, 1995, 72:579-583.
